Table 3 Power calculation
From: Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study
Melatonin, n =  | 42 |
Control, n =  | 42 |
Incidence, melatonin group | 30% |
Incidence, control group | 60% |
Alpha | 0.05 |
Beta | 0.2 |
Power | 0.8 |